Objective: To determine the relationship between, and antibiotic resistance
of, endotracheal tube (ET) biofilm and pulmonary pathogens in ventilator-a
ssociated pneumonia (VAP).
Setting: General intensive care units in two university teaching hospitals.
Design: The microbiology of ET biofilm and tracheal samples from patients w
ith and without VAP were compared. For individual patients, matching pairs
of pathogens were confirmed as identical and characterised for antibiotic s
usceptibility.
Patients: 40 intensive care unit patients - 20 with VAP, 20 without VAP as
control. The duration of intubation (median and range) was 6.5 days (3-17)
and 5 days (2-10), respectively.
Measurements and results: Samples of tracheal secretions were taken during
ventilation for bacteriological culture. Following extubation, ETs were exa
mined for the presence of biofilm. Isolates of high pathogenic potential in
cluded Staphylococcus aureus, enterococci, Enterobacteriaceae, pseudomonads
and Candida spp. Where the same microorganism was found on tracheal and ET
samples by phenotyping, these were confirmed as identical by genotyping an
d characterised for antibiotic susceptibility in both the free floating and
biofilm forms. Seventy per cent of patients with VAP had identical pathoge
ns isolated from both ET biofilm and tracheal secretions. No pairing of pat
hogens was observed in control patients (p < 0.005). Susceptibility data fo
r these pairs show that the ET acts as a reservoir for infecting microorgan
isms which exhibit significantly greater antibiotic resistance than their t
racheal counterparts.
Conclusion: This investigation provides further evidence for the role of ET
biofilm in VAP. The difficulty in eradicating an established microbial bio
film using antibiotics implies that increased attention must be directed to
wards modification of the ET to prevent or substantially reduce biofilm for
mation.